In This Article:
TriNetX has collaborated with Fujitsu to establish TriNetX Japan KK, a joint venture (JV) aimed at transforming the utilisation of anonymised electronic health record (EHR) data from Japanese individuals to accelerate healthcare research and clinical trials.
The collaboration is set to integrate the country more fully into the worldwide data-driven healthcare landscape.
The new entity will leverage TriNetX's LIVE platform, which encompasses a network of more than 200 million records of patients, with Fujitsu's cloud-based platform.
TriNetX LIVE is the largest federated network of real-world data and harmonises diverse datasets including EHRs, lab outcomes and data from the tumour registries into a unified data model.
This facilitates on-demand cohort creation and analysis for researchers and life sciences companies, enabling them to conduct analytics and access large-scale EHR datasets securely.
The JV is in line with the increasing participation of Japanese medical institutions in the TriNetX network.
These institutions are engaging in new studies leveraging TriNetX's technology and data and pharmaceutical companies are extending clinical trial opportunities to them.
TriNetX Japan KK will be led by Shogo Wakabayashi, the country manager for TriNetX in Japan.
TriNetX chief operating officer Steve Kundrot and the company’s mergers and acquisitions and business development vice-president Elizabeth Schwert are set to join the board of directors of the JV.
Fujitsu healthy living head Tatsuki Araki stated: “Fujitsu is proud to collaborate with TriNetX to advance healthcare and life sciences innovation in Japan. Together with TriNetX, we will create an environment where Japanese medical data, previously underutilised, can be efficiently leveraged for clinical research.
“As part of our business model “Fujitsu Uvance,” which is based on addressing social issues, Fujitsu aims to eliminate drug loss in Japan and achieve a society where everyone can choose the treatment that best suits them by creating an ecosystem leveraging medical data.”
"TriNetX and Fujitsu form JV to boost healthcare research in Japan" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.